Westport, CT, Might 04, 2021 (GLOBE NEWSWIRE) —
- The Firm sees elevated expertise utilization throughout its put in base and anticipates enrolling to no less than 1500 circumstances by the top of 2021
- 44 physicians have performed over 800 arrhythmia affected person circumstances so far
- At the moment conducting affected person circumstances in 9 medical facilities throughout the nation together with Texas Cardiac Arrhythmia Institute at St. David’s Medical Middle in Austin, TX, Mayo Clinic Florida Campus and the College of Pennsylvania
BioSig Applied sciences, Inc. (NASDAQ: BSGM) (“BioSig” or the “Firm”), a medical expertise firm commercializing an revolutionary biomedical sign processing platform designed to enhance sign constancy and uncover the total vary of ECG and intra-cardiac alerts, right this moment introduced that it elevated the affected person case objective from 1000 to no less than 1500 procedures by the top of 2021.
BioSig’s non-invasive computerized expertise, the PURE EP™ System, goals to drive procedural effectivity and efficacy in electrophysiology. The system gives important diagnostic alerts with excessive medical worth in all cardiac ablations that deal with irregular heartbeats or arrhythmias.
Beforehand the Firm introduced its goal to finish 1000 affected person circumstances in 2021, having delivered 425 procedures by the top of 2020. The Firm is at present conducting affected person circumstances in 9 medical facilities throughout the nation. Texas Cardiac Arrhythmia Institute at St. David’s Medical Middle in Austin, TX, the Firm’s first business buyer, continues to be the most important consumer of the expertise with over 300 affected person circumstances performed so far. Mayo Clinic Florida Campus and the College of Pennsylvania are the second and third largest affected person case drivers with 130 and 112 circumstances1. Over 800 procedures have been performed with the PURE EP™ System within the final 18 months,
“Affected person case quantity is among the main indications of doctor utilization of our expertise. We see regular procedural development in nearly all of our facilities, which we consider will flip into business revenues. This case development, mixed with the persistently constructive buyer suggestions, positions us nicely to ship on our goal of 20 set up websites by the top of 2021,” commented Kenneth L. Londoner, Chairman and CEO of BioSig Applied sciences, Inc.
One in 18 Individuals suffers from cardiac arrhythmia. Atrial fibrillation is the commonest arrhythmia sort, affecting over 33 million folks worldwide, together with over 6 million within the U.S. The variety of folks affected by atrial fibrillation is predicted to achieve 8-12 million by 20502. In line with the Facilities for Illness Management and Prevention (CDC), atrial fibrillation causes greater than 750,000 hospitalizations within the U.S. annually, leading to roughly $6 billion in healthcare spending yearly3.
About BioSig Applied sciences
BioSig Applied sciences is a medical expertise firm commercializing a proprietary biomedical sign processing platform designed to enhance sign constancy and uncover the total vary of ECG and intra-cardiac alerts (www.biosig.com).
The Firm’s first product, the PURE EP ™ System is a computerized system meant for buying, digitizing, amplifying, filtering, measuring and calculating, displaying, recording and storing of electrocardiographic and intracardiac alerts for sufferers present process electrophysiology (EP) procedures in an EP laboratory.
This press launch accommodates “forward-looking statements.” Such statements could also be preceded by the phrases “intends,” “could,” “will,” “plans,” “expects,” “anticipates,” “initiatives,” “predicts,” “estimates,” “goals,” “believes,” “hopes,” “potential” or comparable phrases. Ahead- trying statements will not be ensures of future efficiency, are based mostly on sure assumptions and are topic to varied identified and unknown dangers and uncertainties, a lot of that are past the Firm’s management, and can’t be predicted or quantified and consequently, precise outcomes could differ materially from these expressed or implied by such forward-looking statements. Such dangers and uncertainties embody, with out limitation, dangers and uncertainties related to (i) the geographic, social and financial impression of COVID-19 on our capability to conduct our enterprise and lift capital sooner or later when wanted, (ii) our incapacity to fabricate our merchandise and product candidates on a business scale on our personal, or in collaboration with third events; (iii) difficulties in acquiring financing on commercially cheap phrases; (iv) adjustments within the measurement and nature of our competitors; (v) lack of a number of key executives or scientists; and (vi) difficulties in securing regulatory approval to market our merchandise and product candidates. Extra detailed details about the Firm and the chance components that will have an effect on the belief of forward-looking statements is ready forth within the Firm’s filings with the Securities and Change Fee (SEC), together with the Firm’s Annual Report on Type 10-Ok and its Quarterly Stories on Type 10-Q. Traders and safety holders are urged to learn these paperwork freed from cost on the SEC’s web site at http://www.sec.gov. The Firm assumes no obligation to publicly replace or revise its forward-looking statements on account of new info, future occasions or in any other case.
1Knowledge as of April 30, 2021.
2Prime 10 Issues You must Know About Coronary heart Rhythm; Scripps Well being.
3Managing Atrial Fibrillation; Lisa Eramom MA, Medical Economics Journal, February 25, 2019, Quantity 96, Concern 4
CONTACT: Andrew Ballou BioSig Applied sciences, Inc. Vice President, Investor Relations 54 Wilton Street, 2nd ground Westport, CT 06880 [email protected] 203-409-5444, x133
— to forextv.com